MedTrace Logo

Ultrasonographic Fetal Soft Markers and Aneuploidy

NCT03861520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-04-07

No results posted yet for this study

Summary

The purpose of this study is to investigate the prevalence of soft markers which will be identified during a second trimester ultrasound. Secondary aims were to estimate the association between the soft markers and trisomies 13, 18 and 21 as well as the effect on the number of invasive tests will be performed.

Conditions

  • Soft Markers

Interventions

DEVICE

Midtrimester anomaly scan

A detailed anomaly scan to detect soft markers at 16 to 24 weeks pregnancy

GENETIC

Fetal Karyotyping

Fetal karyotyping after birth to confirm chromosomal anomaly diagnosed clinically

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Maha M Mossad, MD · Cairo University

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-14
Primary Completion
2020-04-05
Completion
2020-04-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03861520 on ClinicalTrials.gov